• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 8 hours
Earlier today
Yesterday
In the last 7 days
Vaccine Innovations Beyond the Existing mRNA-Based Vaccines for COVID-19 Genetic Engineering and Biotechnology News18:34 3-Oct-24
Quotient Sciences expands with mRNA Focus at CPHI 2024 Outsourcing-Pharma.com08:25 3-Oct-24
Cross-talks eLife19:28 2-Oct-24
New report maps UK leadership in the mRNA revolution UK BioIndustry Association (Press Release)09:47 2-Oct-24
ReCode Announces Two Key Additions to Scientific Advisory Board Business Wire (Press Release)12:32 1-Oct-24
In the last month
ReCode Therapeutics to Participate in Upcoming Investor Conferences Business Wire (Press Release)12:31 25-Sept-24
Building better mRNA for therapeutics Nature.com10:17 23-Sept-24
FDA Approves Updated COVID-19 Vaccines Journal of American Medical Associations16:44 20-Sept-24
All About Alternative Splicing The Scientist16:18 19-Sept-24
USAMRIID researchers contribute to the development of promising mpox vaccine Defense Visual Information Distribution Service15:47 19-Sept-24
NTx Services Launches to Supercharge Next Generation mRNA Research Business Wire (Press Release)14:02 18-Sept-24
Japan approves updated Covid-19 vaccine to tackle JN.1 variant Pharmaceutical Technology18:45 13-Sept-24
Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection Journal of American Medical Associations16:49 13-Sept-24
Cancer jab shows promise in early trial results Belfast Telegraph00:10 13-Sept-24
GSK Stays In mRNA Flu Vaccine Race With Phase II Win Scrip Pharma Intelligence17:03 12-Sept-24
view more headlines
6 Oct 16:16

About our mRNA news

Latest news on mRNA (messenger RNA), covering vaccines, therapeutics, research breakthroughs, clinical trials, and biotech companies like Moderna and BioNTech.

Messenger RNA, or mRNA, has revolutionized the fields of vaccine development and medical therapeutics. The technology gained global attention during the COVID-19 pandemic, with the rapid development and deployment of highly effective mRNA-based vaccines from Pfizer-BioNTech and Moderna. As of April 2024, billions of doses of these vaccines have been administered worldwide, significantly reducing the severity and mortality of COVID-19.

Beyond COVID-19, mRNA technology shows immense promise for treating various diseases, including cancer, genetic disorders, and infectious diseases. Ongoing clinical trials are investigating mRNA-based therapies for conditions such as HIV, influenza, and Zika virus. Additionally, researchers are exploring the potential of personalized mRNA cancer vaccines, which could revolutionize cancer treatment by targeting individual patients' unique tumor profiles.

The success of mRNA vaccines has sparked increased interest and investment in the biotech companies leading this innovation. Moderna and BioNTech have seen significant growth and partnerships with major pharmaceutical companies. The technology's versatility has also attracted the attention of philanthropic organizations, such as the Bill and Melinda Gates Foundation, which are funding research to address global health challenges.

The rapid development and success of mRNA vaccines during the COVID-19 pandemic built upon decades of foundational research. Scientists' understanding of mRNA's role in protein synthesis, combined with advancements in lipid nanoparticle delivery systems, paved the way for this breakthrough. The pandemic accelerated the translation of this research into life-saving interventions, demonstrating the importance of sustained investment in basic science.

As mRNA technology continues to advance, it is crucial to stay informed about the latest developments, clinical trial results, and regulatory approvals. Our NewsNow feed on mRNA provides comprehensive, up-to-date coverage from trusted sources, ensuring you have access to the most relevant information on this groundbreaking field and its impact on global health.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.